No results for ‘’
Samrat Pharmachem Ltd
₹225.95
(0.67%)
Thu, 24 Sept 2026, 06:38 am
Process Industries
Chemicals: Specialty
24.5KSamrat Pharmachem Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 3.84 | 4.21 | 2.46 | 16.15 | 25.90 | 36.08 | 27.50 | 13.91 | 12.15 | 15.02 | 4.37 | 7.88 | 8.72 | 6.89 | 47.64 | 13.59 |
| Price to book ratio | 0.39 | 0.59 | 0.65 | 0.74 | 0.50 | 0.48 | 0.85 | 0.61 | 1.59 | 2.11 | 1.15 | 0.76 | 1.42 | 3.20 | 1.82 | 1.59 | 1.35 |
| Price to sales ratio | 0.07 | 0.10 | 0.13 | 0.13 | 0.09 | 0.10 | 0.24 | 0.13 | 0.34 | 0.42 | 0.21 | 0.13 | 0.23 | 0.68 | 0.37 | 0.37 | 0.34 |
| Price to cash flow ratio | 5.78 | 4.71 | 0 | 2.34 | 0 | 1.53 | 0 | 6.43 | 0 | 0 | 16.28 | 0 | 11.56 | 8.84 | 0 | 11.34 | 0 |
| Enterprise value | 1.87Cr | 2.91Cr | 5.78Cr | 8.26Cr | 8.23Cr | 5.03Cr | 10.68Cr | 8.39Cr | 24.19Cr | 44.49Cr | 27.35Cr | 26.74Cr | 48.27Cr | 143Cr | 121Cr | 102Cr | 106Cr |
| Enterprise value to EBITDA ratio | 4.22 | 1.51 | 2.40 | 1.38 | 7.63 | 8.35 | 9.13 | 7 | 6.54 | 7.57 | 8.67 | 4.06 | 5.40 | 5.85 | 5.02 | 36.10 | 9.94 |
| Debt to equity ratio | 0.38 | 0.22 | 0.22 | 0.27 | 0.35 | 0.24 | 0.24 | 0.40 | 0.45 | 0.51 | 0.33 | 0.39 | 0.30 | 0.16 | 0.30 | 0.13 | 0.14 |
| Return on equity % | 0 | 16.54 | 16.68 | 35.61 | 3.15 | 1.86 | 2.38 | 2.21 | 12.07 | 19 | 7.96 | 19.10 | 19.77 | 44.95 | 30.25 | 3.38 | 10.40 |
Samrat Pharmachem Ltd Enterprise Value
The Samrat Pharmachem Ltd Enterprise Value is a key financial metric used by investors to evaluate Samrat Pharmachem Ltd's valuation, profitability, and overall financial performance. Tracking the Samrat Pharmachem Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Samrat Pharmachem Ltd (NSE: , BSE: 530125) is currently trading at ₹225.95, with a market capitalization of ₹69.35Cr. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Samrat Pharmachem Ltd Enterprise Value is essential for fundamental analysis.
Samrat Pharmachem Ltd Enterprise Value Current Value
The current Samrat Pharmachem Ltd Enterprise Value stands at 106Cr.
The latest Samrat Pharmachem Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Samrat Pharmachem Ltd Enterprise Value Historical Trend
The Samrat Pharmachem Ltd Enterprise Value has shown the following historical trend:
- 2024: 106Cr
- 2023: 102Cr
- 2022: 121Cr
- 2021: 143Cr
- 2020: 48.27Cr
The recent rise in Samrat Pharmachem Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Samrat Pharmachem Ltd Enterprise Value Indicates for Investors
The Samrat Pharmachem Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Samrat Pharmachem Ltd.
Samrat Pharmachem Ltd Enterprise Value Analysis Summary
The Samrat Pharmachem Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Samrat Pharmachem Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Samrat Pharmachem Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.